Table 5 The prevalence of adverse pregnancy outcomes according to the number of out-of-range lipids in middle pregnancy
| Â | N (%) | GDM | OR | Pregnancy-induced hypertension | OR | PE | OR | Macrosomia | OR | LGA | OR | Preterm birth | OR | Total | OR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | Â | N (%) | N (%) | N (%) | |||||||||
Group A | 5245 (81.1%) | 1289 (25.0%) | 1 | 207 (4.0%) | 1 | 110 (2.1%) | 1 | 503 (9.6%) | 1 | 991 (18.9%) | 1 | 230 (4.4%) | 1 | 2247 (42.8%) | 1 |
Group B | 917 (14.2%) | 307 (34.3%) | 1.563 (1.343–1.819) | 66 (7.3%) | 1.616 (1.204–2.168) | 25 (2.8%) | 1.088 (0.692–1.711) | 101 (11.0%) | 1.081 (0.857–1.362) | 211 (23.0%) | 1.186 (0.998–1410) | 60 (6.5%) | 1.332 (0.986–1.800) | 484 (52.8%) | 1.325 (1.142–1.536) |
Group C | 277 (4.3%) | 85 (31.1) | 1.358 (1.043–1.769) | 23 (8.5%) | 1.821 (1.120–2.959) | 12 (4.4%) | 1.503 (0.748–3.022) | 22 (7.9%) | 0.815 (0.521–1.274) | 54 (19.5%) | 1.037 (0.762–1.411) | 30 (10.8%) | 2.217 (1.437–3.421) | 141 (50.9%) | 1.246 (0.967–1.607) |
Group D | 27 (0.4%) | 5 (18.5%) | 0.683 (0.258–1.807) | 3 (11.1%) | 2.643 (0.778–8.982) | 2 (7.4%) | 3.158 (0.724–13.776) | 2 (7.4%) | 0.719 (0.169–3.051) | 6 (22.2%) | 1.165 (0.467–2.909) | 6 (22.2%) | 5.782 (2.246–14.885) | 14 (51.9%) | 1.270 (0.580–2.782) |